Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-06-28
1998-03-31
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
560 41, A61K 3800, C07C22900
Patent
active
057338833
ABSTRACT:
Improved method for crystallization of .alpha.-L-aspartyl-L-phenylalanine methyl ester (aspartame) from an aqueous solution by conductive cooling while avoiding turbulence in the crystallizing system wherein crystallization is carried out with cooling to a temperature level not lower than 10.degree. C. in the presence of at least 0.1% by weight of a C.sub.3-8 ketone, the amount of ketone and the temperature level being chosen for each individual ketone so that a homogeneous solvent system is present at the start of crystallization and an open drainable network of aspartame crystals is obtained.
REFERENCES:
patent: 4962222 (1990-10-01), Mita et al.
patent: 5298648 (1994-03-01), Ebisawa et al.
Hatada et al, J. Amer. Chem. Soc. 107 4279-82 (1985).
Rijkers Marinus P. W. M.
Vrinzen Alexander P. M.
Celsa Bennett
Holland Sweetener Company V.O.F.
Tsang Cecilia J.
LandOfFree
Crystallization of .alpha.-L-aspartyl-L-phenylalanine methyl est does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystallization of .alpha.-L-aspartyl-L-phenylalanine methyl est, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystallization of .alpha.-L-aspartyl-L-phenylalanine methyl est will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-51980